INIS
humans
100%
production
100%
dynamics
100%
salts
100%
intestines
100%
bacillus megaterium
100%
strains
42%
diseases
28%
inflammation
28%
precursor
28%
lysine
28%
levels
14%
comparative evaluations
14%
fatty acids
14%
metabolites
14%
metabolism
14%
complement
14%
in vivo
14%
host
14%
large intestine
14%
conversion
14%
lipids
14%
kinetics
14%
plates
14%
fish oil
14%
biosynthesis
14%
epa
14%
therapeutic uses
14%
Keyphrases
Dynamic Model
100%
N-3 Polyunsaturated Fatty Acids
100%
Human Intestine
100%
Bacillus Megaterium
100%
Pro-resolving Mediators
100%
TIM-2
30%
Inflammatory Bowel Disease
20%
Lysine
20%
Irritable Bowel Syndrome
20%
TIM-1
20%
Placebo
10%
Metabolism
10%
Quantitative PCR
10%
Healthy Individuals
10%
Microbiota
10%
Large Intestine
10%
Intestine
10%
Bacterial Strains
10%
Fecal Microbiota
10%
In Situ
10%
Fish Oil
10%
Engraftment
10%
Therapeutic Use
10%
Esterified
10%
Lipid Mediators
10%
Strain Specificity
10%
Omega-3 Polyunsaturated Fatty Acids
10%
Bioavailable
10%
Plate Counting
10%
18-HEPE
10%
17-HDHA
10%
Metabololipidomics
10%
Resolvin E2
10%
Protectin DX
10%
Immunology and Microbiology
Mediator
100%
Intestine
100%
Bacillus Megaterium
100%
Inflammatory Bowel Disease
18%
Precursor
18%
Lysine
18%
Metabolite
9%
Real-Time Polymerase Chain Reaction
9%
Probiotic
9%
Microflora
9%
Feces microflora
9%
Large Intestine
9%
Engraftment
9%
Bacterial Strain
9%
CD59 Antigen
9%
Pharmacology, Toxicology and Pharmaceutical Science
Bacillus Megaterium
100%
Table Salt
100%
Inflammatory Bowel Disease
28%
Lysine
28%
Irritable Colon
28%
Placebo
14%
Omega-3 Fatty Acid
14%
Fish Oil
14%
Microflora
14%
Feces microflora
14%
Therapeutic Use
14%
Omega 3 Fatty Acid
14%
CD59 Antigen
14%